Comprehensive Stability Study Protocol for Enzyme-Based Drugs
This protocol outlines the procedures for conducting stability studies on enzyme-based drugs, assessing enzyme activity, degradation, and temperature sensitivity under various storage conditions.
| Parameter | Details |
|---|---|
| Product Name | [Enzyme-Based Drug Name] |
| Batch Number | [Batch Number] |
| Objective | To evaluate the stability of enzyme-based drugs under specified environmental conditions. |
| Test Parameters |
– Enzyme Activity – Degradation Products –  |
| Storage Conditions | [e.g., 2-8°C, 25°C/60% RH] |
| Test Intervals | [Specify intervals: 0, 3, 6 months, etc.] |
| Acceptance Criteria | No significant loss of enzyme activity or increased degradation. |
| Regulatory Guidelines | ICH Q1A(R2), FDA, EMA |
| Signatories | QA, QC, Regulatory Affairs |